From research bench to the patient’s bedside
ESMO Congress 2019 held in Barcelona, Spain, from 27 September to 1 October 2019
Adding FOLFIRINOX to nab-PG may improve outcomes in pancreatic cancer
Results from the phase II NEOLAP study presented at ESMO 2019
Oncologists can have a pivotal role in health policy
Effective NCCPs should help medical oncologists to provide better cancer care, but they cannot work in isolation
Sex and gender-sensitive medicine: are we ready to switch paradigm?
Examining sex- and gender-related differences may potentially be the new frontier in the era of precision medicine to tailor cancer treatments in men and women.
Ceritinib demonstrates efficacy in brain metastases in ALK+ NSCLC
Results from ASCEND-7 trial confirms the place of ceritinib as a standard treatment option for patients with ALK+ non-small-cell lung cancer and active brain metastases
Over one hundred ESMO research fellows in 30 years
2019 marks the 30th Anniversary of the ESMO Fellowship Programme, a programme that has provided many young oncologists valuable educational opportunities, shaped professional lives and enhanced careers
